D-0134-2017 Class III Terminated

Recalled by Taro Pharmaceuticals U.S.A., Inc. — Hawthorne, NY

FDA drug recall D-0134-2017 was initiated by Taro Pharmaceuticals U.S.A., Inc. on May 26, 2016 and is designated Class III. Reason for recall: Subpotent Drug: Out of Specification assay values on stability for the active ingredient, zinc pyrithione. The recall status is terminated (terminated Jun 6, 2018). Affected quantity: 17,100 kits.

Recall details

Product Type
Drugs
Report Date
Nov 16, 2016
Initiation Date
May 26, 2016
Termination Date
Jun 6, 2018
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
17,100 kits

Product description

Kamedis BIO-HERBAL DANDRUFF CARE THERAPEUTIC 2-STEP DANDRUFF CARE SYSTEM - Kamedis Bio-Herbal Dandruff Care 0.1% PYRITHIONE ZINC, STEP 1 PRE-TREAT Concentrated Botanical Scalp Lotion (0.1% Pyrithione Zinc) 4.20 FL OZ (125mL) (NDC 51672-2126-0) and STEP 2 CLEANSE Concentrated Botanical Dandruff Shampoo (1.0% Pyrithione Zinc)(0.6.80 FL OZ (200 mL) (NDC 51672-2125-5), Distributed by: Taro Pharmaceuticals U.S.A, Inc. Hawthorne, NY 10532. NDC

Reason for recall

Subpotent Drug: Out of Specification assay values on stability for the active ingredient, zinc pyrithione.

Distribution pattern

Nationwide

Code information

Lot #: E601, E602, E603, E604, E608, E609 - Exp. September 2017; E610 E611, Exp. October 2017

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0134-2017
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0134-2017. Report a data issue: hello@regdatalab.com.